
Blog
PREVENTION Trial Studies Impact of Lifestyle Changes on Alzheimer’s Risk
by Guest Author
Alzheimer’s disease is the leading cause of disability in people older than 65. The PREVENTION Trial from Providence and the Pacific Brain Health Center looks at whether healthy lifestyle changes combined with brain exercises can help prevent Alzheimer’s disease
Dr. Santosh Kesari Ranks Among Top Researchers for Glioblastoma
by Amelia Garrison
Expertscape, a highly regarded ranking site for life science practitioners, recently recognized Dr. Santosh Kesari among the top researchers for glioblastoma, or GBM. Of almost 80,000 publications surveyed, Dr. Kesari’s research ranked in the top 0.05%, making his work a vital component in GBM treatment. Many of Pacific...
Neurodiagnostic Treatment Suite at Pacific Neuroscience Institute
by Zara Jethani
The Pacific Neuroscience Institute’s state-of-the-art Neurodiagnostic Treatment Suite is complete and providing infusion therapies for a variety of neurological conditions including Multiple Sclerosis (MS) and pituitary disorders such as Pituitary Adenomas. Launched in April 2021, the facility represents another convenience for our patients where they...
Embracing the Power of Gratitude
by Zara Jethani
A gratitude study uses beautiful videos on a mobile-based app to enhance well-being and adds to the Visual Healing® studies at Pacific Neuroscience Institute.
Santosh Kesari, MD, PhD, Named Regional Medical Director for the Research Clinical Institute, Providence Southern California
by Guest Author
By Rex Hoffman, MD, Chief Medical Officer, SoCal Clinical Institutes and Chief Medical Officer, Providence Holy Cross Medical Center April 1, 2021 – I am pleased to announce that Santosh Kesari, MD, PhD, has been named regional medical director of Southern California’s Research Clinical Institute....
Pacific Neuroscience Institute Launches New Psychedelic-Assisted Clinical Trial
by Zara Jethani
The Visual Healing® study at PNI tests a nature-themed immersive video experience in psilocybin-assisted therapy for patients with alcohol use disorder.
PNI’s 2020 Year-in-Review & What To Expect in 2021
by Zara Jethani
PNI’s Year-in-Review 2020 was, despite the pandemic, a strong year for clinical care delivered by PNI providers with multiple milestones being achieved. We’ve entered 2021 with a deep commitment to treating our patients at our ten centers of excellence, doing groundbreaking research, providing innovative clinical...
ONCOLOGY Clinical Trials Round-Up: March 2021
by Mini Gill
New Studies EpicentRx Beta-Prime: A Phase I, First in Human, Study to Evaluate the Safety and Tolerability of AdAPT-001 in Subjects with Refractory Solid Tumors (NCT04673942) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade...
The Power of Immunotherapy
by Santosh Kesari
Our immune systems hold the power—the power, that is, to treat cancer. Composed of various types of cells, tissues, and organs, the immune system serves as more than the body’s main defense against foreign invaders such as bacteria and viruses. It also recognizes cancer cells...
PNI Founders’ Message 2021
by Guest Author
Although our medical community continues to strain under the burden of COVID-19, there has been hope, determination and progress. Neurological diseases do not stop and neither have we at Pacific Neuroscience Institute.
Last updated: April 19th, 2021